Results 11 to 20 of about 8,038 (216)
New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group [PDF]
Internal and Emergency Medicine, 2019 The European Eosinophilic Granulomatosis with Polyangiitis (EGPA) study group first gathered in Firenze in December 2018. The discussion was centred around the clinical and therapeutic needs in EGPA which still remain unmet. Indeed, EGPA is a puzzling and rare disease which shares clinical features with other anti-neutrophil cytoplasmic antibody (ANCA)-Marvisi C., Sinico R. A., Salvarani C., Jayne D., Prisco D., Terrier B., Emmi G., Vaglio A., Arndt F., Egan A., Tervaert J. W. C., Hellmich B., Kahn J. -E., Kernder A., Mahr A., Mahrhold J., Neumann T., Schiavon F., Troilo A., Urban M. L., Venhoff N. +20 morecore +10 more sourcesHES and EGPA
Mayo Clinic Proceedings, 2023 Elevated eosinophil counts are implicated in multiple diseases, from relatively prevalent organ-specific disorders such as severe eosinophilic asthma, to rare multisystem disorders such as hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA).Paneez Khoury, Praveen Akuthota, Namhee Kwon, Jonathan Steinfeld, Florence Roufosse +4 moreopenaire +4 more sourcesImmunological Markers Associated with Skin Manifestations of EGPA
International Journal of Molecular SciencesEosinophilic Granulomatosis with Polyangiitis (EGPA) is a rare systemic vasculitis with eosinophilic inflammation and variable clinical presentations. Although skin manifestations are frequent, current classification criteria do not include them, which may underestimate their diagnostic value.Silvia Brunetto, Federica Buta, Sebastiano Gangemi, Luisa Ricciardi +3 moreopenaire +5 more sourcesMepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study [PDF]
, 2021 Mepolizumab proved efficacious for eosinophilic granulomatosis with polyangiitis (EGPA, former Churg-Strauss) at the dosage of 300mg/4 weeks in the randomized controlled MIRRA trial.Lombardi, Carlo, Jayne, David, Chiara Baldini, Maxime Samson, Vincent Cottin, Crimi, Claudia, Moroni, Luca, Anna Luise Kernder, European EGPA Study Group, Jan Schroeder, Padoan, Roberto, Claudia Crimi, Dagna, Lorenzo, Filippo Fagni, Egan, Allyson, Giacomo Emmi, Franceschini, Franco, Schiavon, Franco, Federico Alberici, Angelo Vacca, Florenzo Iannone, Mouhamad Nasser, David Jayne, Allyson Egan, Urban, Maria Letizia, Nasser, Mouhamad, Berti, Alvise, Federica Bello, Paola Toniati, Fraticelli, Paolo, Domenico Prisco, Fagni, Filippo, Baldini, Chiara, Moosig, Frank, Carlo Salvarani, Mohammad, Aladdin J., Franco Schiavon, Monti, Sara, Mohammad, Aladdin J, Luca Moroni, Neumann, Thomas, Simone Negrini, Giuseppe Lopalco, Carlo Lombardi, Schroeder, Jan, Pavel Novikov, Bernhard Hellmich, Davide Firinu, Ribi, Camillo, Georgina Espígol-Frigolé, Cohen Tervaert, Jan Willem, Cottin, Vincent, Lunardi, Claudio, Kernder, Anna Luise, Chiara Marvisi, Sinico, Renato Alberto, Roccatello, Dario, Frank Moosig, Renato Alberto Sinico, Samson, Maxime, Parronchi, Paola, Marco Folci, Salvarani, Carlo, Novikov, Pavel, Espígol-Frigolé, Georgina, Maria Letizia Urban, Bettiol, Alessandra, Toniati, Paola, Thomas Neumann, Ramirez, Giuseppe Alvise, Firinu, Davide, Paolo Fraticelli, Vaglio, Augusto, Silvagni, Ettore, Prisco, Domenico, Fiori, Davide, Marvisi, Chiara, Iannone, Florenzo, Jan Willem Cohen Tervaert, Quartuccio, Luca, Ettore Silvagni, Franco Franceschini, Benjamin Seeliger, Cinetto, Francesco, Aladdin J. Mohammad, Emmi, Giacomo, Roberto Padoan, Giuseppe Alvise Ramirez, Espígol‐Frigolé, Georgina, Paola Parronchi, Lorenzo Dagna, Vacca, Angelo, Luca Quartuccio, Georgina Espígol‐Frigolé, Francesco Cinetto, Sara Monti, Stefano Del Giacco, Negrini, Simone, Alessandra Bettiol, Dario Roccatello, Hellmich, Bernhard, Seeliger, Benjamin, Bargagli, Elena, Davide Fiori, Bello, Federica, Augusto Vaglio, Lopalco, Giuseppe, Aladdin J Mohammad, Del Giacco, Stefano, Folci, Marco, Elena Bargagli, Alberici, Federico, Camillo Ribi, Alvise Berti, Claudio Lunardi +114 morecore +5 more sourcesChronic Rhinosinusitis and Nasal Polyps in Eosinophilic Granulomatosis With Polyangiitis: A Scoping Review. [PDF]
Int Forum Allergy RhinolABSTRACT Background
Chronic rhinosinusitis (CRS) is one of the most common manifestations of eosinophilic granulomatosis with polyangiitis (EGPA), often preceding the diagnosis of systemic vasculitis by several years. The sinonasal presentation of EGPA typically resembles CRS with nasal polyps (CRSwNP), making it clinically indistinguishable from those Sharma A, Li AY, Kishibe T, Wong D, Sanders KM, Jiang M, Lee H, Song C, Mcintyre K, Pagnoux C, Chan Y, Lee JM, Lee DJ. +12 moreeuropepmc +2 more sourcesConclusion: EGPA, EPPA and the Future of Public Administration in Europe
, 2018 This chapter outlines the strategy of the European Group for Public Administration (EGPA) and reflects on some of its key strengths, and how these may equip the European community of scholars and practitioners of public administration (PA) to contribute to the development of the field. The chapter reviews the key trait of the EGPA organisational model: Bouckaert, Geert, Jann, Werner (Prof. Dr.), Maron, Fabienne, Ongaro, Edoardo, Sofiane, Sahraoui +4 moreopenaire +3 more sourcesSequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study [PDF]
, 2022 Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational ...Flossmann, Oliver, Marc André, Maria Letizia Urban, Jayne, David, Bettiol, Alessandra, Egan, A., Emmi, G., Irene Mattioli, Vaglio, Augusto, Prisco, Domenico, Fiori, Davide, Jan Schroeder, Padoan, Roberto, Dagna, Lorenzo, Iannone, Florenzo, Egan, Allyson, Giacomo Emmi, André, M., Franceschini, Franco, Vaglio, A., Florenzo Iannone, Negrini, S., Schroeder, J., David Jayne, Franceschini, F., Allyson Egan, Urban, Maria Letizia, Franco Franceschini, Oliver Flossmann, Dagna, L., Federica Bello, Bargagli, E., Moi, L., Silvestri, Elena, Emmi, Giacomo, Roberto Padoan, Laura Moi, Domenico Prisco, Sciascia, Savino, Caminati, M., Sciascia, S., Paola Parronchi, Prisco, D., André, Marc, Lorenzo Dagna, Padoan, R., Fiori, D., Marco Caminati, Bello, F., Solans, R., Jayne, D., Negrini, Simone, Alessandra Bettiol, Simone Negrini, Giuseppe Lopalco, Dario Roccatello, Urban, M.L., Moi, Laura, Bettiol, A., Parronchi, P., Caminati, Marco, Schroeder, Jan, Roser Solans, Bargagli, Elena, Davide Fiori, Mattioli, Irene, Mattioli, I., Bello, Federica, Augusto Vaglio, Lopalco, Giuseppe, Iannone, F., Flossmann, O., Folci, Marco, Elena Bargagli, Roccatello, D., Roccatello, Dario, Savino Sciascia, Parronchi, Paola, Marco Folci, Folci, M., Solans, Roser, Lopalco, G. +81 morecore +1 more sourceUpdates for the treatment of EGPA
La Presse Médicale, 2020 Eosinophilic granulomatosis with polyangiitis (EGPA, formerly Churg-Strauss syndrome) is the least frequent antineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV). Major advances of our knowledge on its pathophysiology have revealed features of both AAV and eosinophilic disorders. The development of targeted biotherapies for both diseases Raffray, Loïc, Guillevin, Loïcopenaire +2 more sourcesBenralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study.
, 2023 Interleukin-5 (IL-5) inhibitors represent novel therapies for eosinophilic granulomatosis with polyangiitis (EGPA). This study assessed the effectiveness and safety of the IL-5 receptor inhibitor benralizumab in a European cohort of patients with EGPA ...Cinetto, F., Bianchi, F.C., Cathébras, P., Venerito, V., Egan, A., Fraticelli, P., Emmi, G., Del Giacco, S., Lombardi, C., Espígol-Frigolé, G., Costanzo, GAML, Gullo, A.L., Schroeder, J.W., Vaglio, A., Groh, M., Coppola, A., Moroncini, G., Cottin, V., Rivera, C.M., Novikov, P., Moi, L., Ribi, C., Nolasco, S., Gelain, E., Caminati, M., Losappio, L., Prisco, D., Kahn, J.E., Padoan, R., Desaintjean, C., Tesi, M., Bello, F., Marchi, M.R., Solans, R., Jayne, D., Urban, M.L., Bettiol, A., Parronchi, P., Monti, S., Vacca, A., Cameli, P., Mattioli, I., Iannone, F., Tcherakian, C., Crimi, C., Durel, C.A., Berti, A., Folci, M., Guarnieri, G., Lopalco, G. +49 morecore +1 more source
